Academic Highlights: Transcranial Magnetic Stimulation: Potential New Treatment for Resistant Depression. [CME]
J Clin Psychiatry 2007;68(2):315-330
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Major depression is a common disorder and substantial cause of disease burden worldwide. Nearly 60% of patients with depression may not achieve adequate response following antidepressant treatment.1 New somatic treatments that are less invasive than electroconvulsive therapy (ECT), such as transcranial magnetic stimulation (TMS), are being added to the repertoire of treatments that have the potential to be effective in depression that is resistant to pharmacologic therapies.